Celularity Inc. (NASDAQ: CELU) Stock Information | RedChip

Celularity Inc. (NASDAQ: CELU)


$2.1050
+0.6550 ( +45.17% ) 8.3M

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Market Data


Open


$2.1050

Previous close


$1.4500

Volume


8.3M

Market cap


$46.17M

Day range


$1.5050 - $2.6350

52 week range


$1.3000 - $7.9700

SEC Filings


Form Type Description Pages Date
8-k 8K-related 11 Jan 09, 2024
10-q Quarterly Reports 94 Jan 03, 2024
8-k 8K-related 13 Dec 29, 2023
8-k 8K-related 13 Nov 24, 2023
nt Quarterly Reports 1 Nov 14, 2023

Latest News